A longtime leader in healthcare improvement, we’re developing new ways to revolutionize the industry.
Premier shares recommendations and insights with the House Energy and Commerce Health Subcommittee related to the role of AI in healthcare.
Watch this on-demand webinar for an overview of how the policies included in these final rules could impact your organization.
The PINC AI™ Applied Sciences team and their partners continue their work to develop long-lasting solutions to our nation’s health equity crisis.
Premier recommends ways for FDA to incorporate emerging technologies into drug development and provide clarity for manufacturers.
Premier urges the DEA to ensure reductions in opioid manufacturing quotas do not exacerbate recent drug shortages.
PINC AI™ Applied Sciences is committed to advancing health equity through real-world, data-driven research and solutions co-designed with health systems and life sciences partners.
Life sciences companies need to invest in RWD/RWE as payers, regulatory bodies, and health systems demand proof that a medical solution delivers real value.
Premier joined 100 other healthcare organizations in urging Congress to reauthorize PAHPA before the end of the year.
PM360 |
Data clearly matters in pharma. For the fourth year in a row AI and Big Data ranked as the most impactful technologies in the industry.
Premier urged Congress to pass legislation to strengthen our nation’s healthcare infrastructure, improve patient access to care and lower the cost of care.
Watch this on-demand webinar for a deep dive into the current policy landscape around dementia care, including an overview of this new CMS Innovation Center...
Premier identifies opportunities for Congressional and administrative involvement in AI governance.